Jiangsu Kanion Pharmaceutical Co.,Ltd.’s Net Profit Rose 31.6% in First Quarter of 2023

Jiangsu Kanion Pharmaceutical Co.,Ltd. (江苏康缘药业股份有限公司) (600557.SH) reported a net profit of 145.3 million yuan in the first quarter of 2023, up 31.6% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 25.4% year-on-year.

At the end of the reporting period, it had 6.7 billion yuan in total assets and 1.6 billion yuan in total liabilities, with a liability-to-asset ratio of 24.4%.